Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood

Transfusion

Volumn 41, Issue 10, 2001, Pages 1299-1305

  Salvaneschi, Laura ^a,b,c   Perotti, Cesare ^a,b   Zecca, Marco ^a,b   Bernuzzi, Stefano ^a,b   Viarengo, Gianluca ^a,b   Giorgiani, Giovanna ^a,b   Del Fante, Claudia ^a,b   Bergamaschi, Paola ^a,b   Maccario, Rita ^a,b   Pession, Andrea ^a,b   Locatelli, Franco ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHOXSALEN; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; GRAFT VERSUS HOST REACTION; HEART RATE VARIABILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DRUG RESISTANCE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PHOTOPHERESIS; PROSPECTIVE STUDIES; STEROIDS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034782157     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41101299.x     Document Type: Article

References (42)

1. Graft-versus-host disease
2. In vivo prevention and treatment of GVHD
3. Chronic graft-versus-host disease
4. Management of graft-versus-host disease in paediatric bone marrow transplant recipients
5. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment
6. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
7. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome
8. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone
9. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment
10. ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival
11. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation
12. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease
13. Treatment of acute graft versus host disease with humanized anti-Tac: An antibody that binds to the interleukin-2 receptor
14. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants
15. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: Prognostic influence of prolonged thrombocytopenia after aliogeneic marrow transplantation
16. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease
17. Treatment of chronic graft-versus-host disease with clofazimine
18. Total lymphoid irradiation for treatment of drug resistant chronic GVHD
19. Extracorporeal photochemotherapy: A scientific overview
20. Photopheresis for the prevention of rejection in cardiac transplantation
21. Feasibility and safety of a new technique of extracorporeal photochemotherapy: Experience of 240 procedures
22. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease
23. Extracorporeal photochemotherapy in the treatment of severe, steroid-resistant acute graft-versus-host disease: A pilot study
24. Phototherapy in the treatment of cutaneous graft-versus-host disease
25. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis
26. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease
27. Photopheresis in patients with drug-resistant chronic graft-versus-host disease
28. Treatment of graft-versus-host disease with photopheresis
29. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
30. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
31. Human cytomegalovirus infection in pediatric patients given allogeneic bone marrow transplantation: Role of early treatment of antigenemia on patients' outcome
32. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (EPC)
33. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: A pilot study
34. Increased risk of infection in marrow transplant patients receiving methyl-prednisolone for graft-versus-host disease prevention
35. Avascular necrosis of bone after cardiac transplantation. Prevalence and relationship to administration and dosage of steroids
36. Graft-versus-host disease in children: The AIEOP-BMT Group experience with cyclosporin A
37. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients
38. Unsaturated fatty acids psolarens cycloadducts play a role of second messenger and diacylgycerol
39. Cell membrane DNA: A new target for psolaren photoadduct formation
40. Photopheresis treatment enhances CD95 (FAS) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis
41. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma
42. Photochemotherapy of GVHD